MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF)…
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
Product sales and commercial rights revenues in 2025 increased 90% year-over-year to…
Nexteer Reports 2025 Year End Results
Continues Above-Market Growth with Expanding MarginsAUBURN HILLS, Mich., March 24, 2026 /PRNewswire/…
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
Group PerformanceRevenue: US$959.5 million, +61.4% year-on-yearGross profit: US$553.2 million, +103.3% year-on-yearAdjusted net…
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
March 20, 2026 13:30 ET | Source: SANUWAVE Health, Inc. EDEN PRAIRIE,…
SafeSpace Global Corporation Reports Q2 Fiscal 2026 Financial Results; Company Transitions from Pre-Revenue to Revenue-Generating Stage, Expands Footprint with Nashville Office, and Initiates Steps Toward National Exchange Uplisting
KNOXVILLE, TN., March 20, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:…
Crescel Reports Positive Randomized Controlled Trial Results for Biobotanical Skin Renewal Cream in Rosacea
Study Shows Greater Clinical Improvement vs. Metronidazole-Based Standard of Care with Favorable TolerabilityMIAMI…
Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
DALLAS, March 16, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG), a leading Bitcoin…
VitalHub Reports Fourth Quarter 2025 Results
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 35% YoY to $96.1 millionTotal Revenue up…
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
March 12, 2026 21:03 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
